Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 20 family member A5, pseudogene (ANKRD20A5P), is a human pseudogene located on chromosome 19q13.33 that is related to the ankyrin repeat domain-containing family of proteins. While its name suggests a similarity to the ankyrin repeat-containing protein family, ANKRD20A5P does not encode a functional protein. There are no known direct biological functions, disease associations, or pharmacological roles for the isolated pseudogene. However, in rare cases, ANKRD20A5P can participate as a partner in fusion genes (for example, RPL18-ANKRD20A5P), but its role in these events has not been characterized as therapeutically relevant or as having a clear disease mechanism. No drugs, biomarkers, or clinical safety concerns are associated with this gene or its product.
No mechanism of action because it is not a druggable target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A5, pseudogene (ANKRD20A5P).